title: Nephrogenic fibrosing dermopathy in a patient with systemic lupus erythematosus and acute lupus nephritis.
abstract: Nephrogenic fibrosing dermopathy is a recently recognized skin disorder similar in appearance to scleromyxedema but without the systemic involvement. We describe a 14-year-old girl with new-onset systemic lupus erythematosus and acute lupus nephritis who developed on the lower extremities confluent hyperpigmented, woody, indurated plaques that contained groups of coalescing erythematous papules. Nephrogenic fibrosing dermopathy was diagnosed histologically. Possible etiologies are discussed.
authors.affiliation: Department of Dermatology, University of Texas Medical Branch, Galveston, Texas 77555-0783, USA.
authors.forename: Monica
authors.initials: M
authors.lastname: Sanchez-Ross
authors.forename: Renée
authors.initials: R
authors.lastname: Snyder
authors.forename: María I
authors.initials: MI
authors.lastname: Colome-Grimmer
authors.forename: Mark
authors.initials: M
authors.lastname: Blumberg
authors.forename: Yve
authors.initials: Y
authors.lastname: Huttenbach
authors.forename: Sharon
authors.initials: S
authors.lastname: Raimer
mesh_terms: D000293:Adolescent; D018501:Antirheumatic Agents / Q000627:therapeutic use; D005260:Female; D005355:Fibrosis; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D017495:Hyperpigmentation / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D008181:Lupus Nephritis / Q000150:complications*; D012871:Skin Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine